Company / Book Value per Share
MoonLake Immunotherapeutics Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.723
FY2025
5-year range
-$1.485 / $10.453
FY2021-FY2025
Trend
-33.5%
vs FY2024
Sector context
#107 of 209
Health Care
What the data says
At $4.723, MoonLake Immunotherapeutics's book value per share ranks #107 of 209 in the Health Care sector. Declined from $10.453 to $4.723 over the past 2 years.
Based on SEC 10-K filings.
$4.723 in FY2025 with a 3-year CAGR of +26.3%.
Declined from $10.453 to $4.723 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#107 of 209 in Health CareTop 51% of 209This company $4.723 Sector average $189.406
▼
-97.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +26.3%, indicating consistent growth.
- In FY2025, book value per share decreased 33.5% year-over-year.
- Ranks #107 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.723 | -33.5% |
| FY2024 | $7.107 | -32.0% |
| FY2023 | $10.453 | +346.3% |
| FY2022 | $2.342 | +257.7% |
| FY2021 | -$1.485 | -267.8% |
| FY2020 | -$0.404 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026